Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-07-13

Clinical Trial Update: Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Fibrin Sealant 2 in vascular surgical procedures has completed, studying peripheral vascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrin Sealant 2 (fibrin sealant)

Snippet

Sponsor: Ethicon, Inc. | Conditions: Peripheral Vascular Disease | Phase 3 | Status: COMPLETED